National Pension Service Purchases 3,697 Shares of STERIS plc $STE

Posted by George Bondi on Jun 1st, 2026

National Pension Service grew its position in STERIS plc (NYSE:STE – Free Report) by 2.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 172,499 shares of the medical equipment provider’s stock after acquiring an additional 3,697 shares during the quarter. National Pension Service’s holdings in STERIS were worth $43,732,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in STERIS by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 12,286,535 shares of the medical equipment provider’s stock worth $3,114,882,000 after acquiring an additional 73,014 shares during the last quarter. State Street Corp increased its stake in STERIS by 4.0% in the 3rd quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock worth $1,077,564,000 after acquiring an additional 166,736 shares during the last quarter. Geode Capital Management LLC increased its stake in STERIS by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 2,523,620 shares of the medical equipment provider’s stock worth $637,259,000 after acquiring an additional 14,151 shares during the last quarter. Orbis Allan Gray Ltd increased its stake in STERIS by 36.0% in the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after acquiring an additional 556,088 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in STERIS by 16.4% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock worth $387,797,000 after acquiring an additional 221,199 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the business’s stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the transaction, the director owned 705 shares in the company, valued at $167,233.05. The trade was a 81.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.07% of the stock is currently owned by insiders.

STERIS Price Performance

Shares of STERIS stock opened at $212.52 on Monday. The stock has a market cap of $20.84 billion, a price-to-earnings ratio of 26.80 and a beta of 0.93. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. The stock has a 50 day moving average price of $218.24 and a 200-day moving average price of $240.76. STERIS plc has a one year low of $195.14 and a one year high of $269.44.

STERIS (NYSE:STE – Get Free Report) last announced its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.59 billion. STERIS had a return on equity of 14.15% and a net margin of 13.18%.STERIS’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.74 EPS. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities analysts expect that STERIS plc will post 11.18 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 8th will be issued a dividend of $0.63 per share. The ex-dividend date is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a yield of 1.2%. STERIS’s payout ratio is presently 31.78%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $270.00 price objective on shares of STERIS in a research note on Thursday, May 21st. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday. KeyCorp dropped their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Finally, Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Check Out Our Latest Report on STE

STERIS Profile

(Free Report)

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.